Search for Clinical Trial Results
Primary Liver Cancer - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer Condition: Carcinoma, Hepatocellular Date: 2015-12-15 Interventions: Procedure: Enhanced Recovery After Surgery Before operatio |
Not yet recruiting |
Study Name: The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG Condition: Hepatocellular Carcinoma (HCC) Date: 2017-04-30 Interventions: Radiation: Ga-68-PSMA scan, and PET -CT F-18-FDG The patie |
Completed |
Study Name: Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT) Condition:
|
Completed |
Study Name: Evaluation of Preoperative Investigations in Patients With Liver Cancer Condition:
Date: 2006-12-05 Interventions: Procedure: PET/CT scan and EUS |
Active, not recruiting |
Study Name: rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors Condition:
Date: 2010-01-13 Interventions: Biological: administration of rRp450 into the hepatic artery Administration of rRp450 into the hepatic a |
Active, not recruiting |
Study Name: Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions Condition:
Date: 2013-07-23 Interventions: Procedure: ultrasound elasticity imaging Undergo ultrasound elastography |
Active, not recruiting |
Study Name: S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C Infection Condition:
Date: 2007-08-06 Interventions:
|
Completed |
Study Name: Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC Condition: Primary Liver Carcinoma Date: 2013-12-08 Interventions:
|
Recruiting |
Study Name: Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors Condition: Primary Malignant Liver Neoplasm Date: 2017-04-06 Interventions:
|
Active, not recruiting |
Study Name: PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer Condition:
|